En Es
Categories

Agena Bioscience

Agena Bioscience

Agena Bioscience is dedicated to advancing the impact of genomics in healthcare and precision medicine with a mission is to equip genomic and clinical testing laboratories with practical solutions that increase productivity and decrease time to results. Whether assessing sample quality, screening samples for actionabl ...
Silver member
Products Covid-19NewsSummary
Close

Covid-19 Agena Bioscience

Clinical Laboratory

Mass Spectrometer
MassARRAY System

The MassARRAY System workflow couples mass spectrometry with end-point PCR, enabling highly multiplexed reactions under universal cycling conditions to provide accurate, sensitive and rapid genetic analysis. Available in 96 and 384-well plate formats, the open platform can grow with the lab and simplify the genetic testing process with easy-to-interpret data, fast turn-around times, and broad genetic coverage.
More details

Multiplex Genetic Analyzer
MassARRAY Dx Analyzer

The MassARRAY Dx Analyzer is a benchtop multiplex genetic analyzer that simplifies the complex clinical genetics environment with easy-to-interpret data, flexible biomarker detection and robust performance. Placed at the center of the clinical workflow, labs can optimize throughput, turn-around-times, and data analysis. As their need for marker coverage expands, labs will be empowered to provide targeted patient diagnostics more quickly, which ultimately leads to faster treatment decisions.
More details
Close

News of Agena Bioscience

Mesa Laboratories comprará la compañía de herramientas de diagnóstico molecular Agena Bioscience

26 Oct 2021
Mesa Laboratories comprará la compañía de herramientas de diagnóstico molecular Agena Bioscience
Mesa Laboratories, Inc. (Lakewood, CO, EUA) firmó un acuerdo definitivo para adquirir Agena Bioscience, Inc. (San Diego, CA, EUA).
Read More

Mesa Laboratories to Acquire Molecular Diagnostics Tools Company Agena Bioscience

15 Sep 2021
Mesa Laboratories to Acquire Molecular Diagnostics Tools Company Agena Bioscience
Mesa Laboratories, Inc. (Lakewood, CO, USA) has entered into a definitive agreement to acquire Agena Bioscience, Inc. (San Diego, CA, USA).
Read More
Close

About Agena Bioscience

Agena Bioscience is dedicated to advancing the impact of genomics in healthcare and precision medicine with a mission is to equip genomic and clinical testing laboratories with practical solutions that increase productivity and decrease time to results. Whether assessing sample quality, screening samples for actionable mutations, or enabling routine genetic testing for tens to thousands of samples, the company’s products and services help laboratories translate genomic discoveries into mainstream clinical practice.

Recently updated

Melanoma Test
iPLEX HS Melanoma Panel

The iPLEX HS Melanoma panel enables tumor profiling studies of melanoma specimens and can detect more than 90 clinically relevant variants from BRAF, KIT, NRAS, TERT, and other genes. It can identify variants at as low as 1% variant allele frequency using as little as 10 ng of DNA, requiring one hour of hands-on time and eight hours of total time.
More details

Sample Management
iPLEX Pro Sample ID Panel

The iPLEX Pro Sample ID Panel leverages the power of genetic testing to provide rapid and accurate sample identification and authentication. Forty-four SNPs are used to generate a sample’s unique genetic fingerprint which is analyzed using the MassARRAY system. The automated reporter compares SNP profiles and generates a “Match” or “Mismatch” result for easy identification and authentication of patient specimens with a high degree of certainty.
More details

Cystic Fibrosis Test
CFTR Panel

The Cystic Fibrosis (CFTR) Panel is a cost-effective way to detect 74 of the most common variants of the CFTR gene, including the 23 mutations recommended by ACMG and ACOG. It can detect 51 additional variants with known CFTR relevance and allele frequency >0.1%.
More details

Clinical Laboratory

Melanoma Test
iPLEX HS Melanoma Panel

The iPLEX HS Melanoma panel enables tumor profiling studies of melanoma specimens and can detect more than 90 clinically relevant variants from BRAF, KIT, NRAS, TERT, and other genes. It can identify variants at as low as 1% variant allele frequency using as little as 10 ng of DNA, requiring one hour of hands-on time and eight hours of total time.
More details

Sample Management
iPLEX Pro Sample ID Panel

The iPLEX Pro Sample ID Panel leverages the power of genetic testing to provide rapid and accurate sample identification and authentication. Forty-four SNPs are used to generate a sample’s unique genetic fingerprint which is analyzed using the MassARRAY system. The automated reporter compares SNP profiles and generates a “Match” or “Mismatch” result for easy identification and authentication of patient specimens with a high degree of certainty.
More details

Cystic Fibrosis Test
CFTR Panel

The Cystic Fibrosis (CFTR) Panel is a cost-effective way to detect 74 of the most common variants of the CFTR gene, including the 23 mutations recommended by ACMG and ACOG. It can detect 51 additional variants with known CFTR relevance and allele frequency >0.1%.
More details

Lung Cancer Test
iPLEX HS Lung Panel

The iPLEX HS Lung Panel enables tumor profiling studies of non-small cell lung cancer specimens and can detect 70 clinically relevant variants across BRAF, EGFR, ERBB2, KRAS, and PIK3CA. It can identify variants at as low as 1% variant allele frequency using as little as 10 ng of DNA, making it an ideal screening tool for detecting clinically actionable DNA variants in lung cancer patients.
More details

Melanoma Panel
UltraSEEK Melanoma Panel

The UltraSEEK Melanoma Panel is a liquid biopsy panel for the detection of variants in melanoma from cfDNA and enables the study of disease progression and resistance in melanomas. It detects more than 55 clinically relevant variants across 13 genes, including BRAF, KIT, and NRAS, and can identify variants at as low as 0.1% variant allele frequency.
More details

EGFR Panel
UltraSEEK EGFR Panel

The UltraSEEK EGFR Panel is a liquid biopsy panel for the detection of EGFR resistance markers from cfDNA and is ideally suited for residual disease and resistance monitoring studies in non-small cell lung cancer. It detects six clinically relevant EGFR variants including T790M, C797S, E746_A750del, and L858R, and can identify variants at as low as 0.1% variant allele frequency.
More details

Colon Cancer Mutation Panel
UltraSEEK Colon Panel

The UltraSEEK Colon Panel enables study of disease progression and resistance in colorectal cancer and detects over 100 clinically relevant variants across BRAF, EGFR, KRAS, NRAS and PIK3CA. It can identify variants at as low as 0.1% variant allele frequency using as little as 10 ng of cfDNA and has one hour of hands-on time and eight hours of total time.
More details

Lung Cancer Mutation Panel
UltraSEEK Lung Panel

The UltraSEEK Lung Panel enables study of disease progression and resistance in non-small cell lung cancer and detects over 70 clinically relevant variants across BRAF, EGFR, ERBB2, KRAS and PIK3CA. It can identify variants at as low as 0.1% variant allele frequency using as little as 10 ng of cfDNA and has one hour of hands-on time and eight hours of total time.
More details

Breast Cancer Assay Panel
ClearSEEK PIK3CA Panel

The ClearSEEK PIK3CA Panel enables tumor profiling studies of breast cancer specimens by targeting a set of 20 variants in the PIK3CA mutated gene associated with response to targeted therapy, including the activating mutations recommended by the National Comprehensive Cancer Network Guidelines. The assay panel set is available for use on the MassARRAY System with chip prep module in 96-format and achieves DNA to data in as little as eight hours with minimal manual processing time for greater lab efficiency.
More details

Multiplex Genetic Analyzer
MassARRAY Dx Analyzer

The MassARRAY Dx Analyzer is a benchtop multiplex genetic analyzer that simplifies the complex clinical genetics environment with easy-to-interpret data, flexible biomarker detection and robust performance. Placed at the center of the clinical workflow, labs can optimize throughput, turn-around-times, and data analysis. As their need for marker coverage expands, labs will be empowered to provide targeted patient diagnostics more quickly, which ultimately leads to faster treatment decisions.
More details

Mass Spectrometer
MassARRAY System

The MassARRAY System workflow couples mass spectrometry with end-point PCR, enabling highly multiplexed reactions under universal cycling conditions to provide accurate, sensitive and rapid genetic analysis. Available in 96 and 384-well plate formats, the open platform can grow with the lab and simplify the genetic testing process with easy-to-interpret data, fast turn-around times, and broad genetic coverage.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions